GRIB. Research Unit on Biomedical Informatics

News & activities

Author: Adrià Pérez; KIX-cMyb binding pathway

Thesis defence of Adrià Pérez: "Learning How to Simulate: applying machine learning methods to improve molecular dynamics simulations"

Next ​Thursday 27th of January at 10:00 am, Adrià Pérez, member of the Computational Science group of GRIB will read his thesis: "Learning How to Simulate: applying machine learning methods to improve molecular dynamics simulations".

The event will be online. Free access at

More info...

Lilian Boll obtains one of the grants of the INPhINIT PhD program of La Caixa Foundation

We welcome the predoctoral researcher Lilian Boll who has obtained one of the 65 grants of the INPhINIT PhD Program of La Caixa Foundation for her project "Identification of neo-epitopes in cancer derived from non-canonical proteins and their potential use in immunotherapy" to study neoantigens at the Evolutionary Genomics group of the GRIB.

Neoantigens are tumor-specific antigens generated by mutations in tumor cells, which are only expressed in tumor cells. "One of the approaches in immunotherapy is to block cellular checkpoints so that the immune system recognizes tumor cells by their neoantigens," explains Lilian Boll. "With data from oncology patients, I want to characterize neoantigens genomically and structurally to better understand how we can use them to predict treatment response in patients" adds the researcher.

This grant, aimed at researchers of all nationalities who are interested in carrying out doctoral studies in Spain or Portugal, will allow Boll to carry out the project over 3 years and with a total financial endowment of 122,592 euros for the entire period. In addition, the grant includes a comprehensive complementary training program in soft skills, researcher welfare and preparation for the future.

More info...

More news RSS

Last project

IMPaCT Data es el Programa de Ciencia de Datos de la Infraestructura de Medicina de Precisión asociada a la Ciencia y la Tecnología (IMPaCT), en el que participan 47 instituciones de todas las comunidades, con institutos de investigación sanitaria, empresas, universidades o centros de investigación. Este proyecto está financiado por el Instituto de Salud Carlos III para el periodo 2021 a 2023.

More projects

Last publications

More publications

Site Information